Salt supplementation blunts the blood pressure response to telmisartan with or without hydrochlorothiazide in hypertensive patients with type 2 diabetes. [electronic resource]
Producer: 20100827Description: 1295-303 p. digitalISSN:- 1432-0428
- Antihypertensive Agents -- pharmacology
- Benzimidazoles -- pharmacology
- Benzoates -- pharmacology
- Blood Pressure -- drug effects
- Diabetes Mellitus, Type 2 -- drug therapy
- Double-Blind Method
- Female
- Humans
- Hydrochlorothiazide -- pharmacology
- Hypertension -- drug therapy
- Male
- Middle Aged
- Sodium Chloride, Dietary -- pharmacology
- Telmisartan
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.